A New Look at Osteoporosis Outcomes: The Influence of Treatment, Compliance, Persistence, and Adherence

Badamgarav, Enkhe; Fitzpatrick, Lorraine A.
August 2006
Mayo Clinic Proceedings;Aug2006, Vol. 81 Issue 8, p1009
Academic Journal
The article presents a discussion on the influence of persistence, adherence, compliance and treatment for osteoporosis. It mentions that osteoporosis is a disease in which excess in bone resorption leads to decreased bone mass and an increase in its fragility. It emphasizes that for osteoporosis, which requires long-term therapy, it is significant to comprehend how the behavior of patients taking drugs affect the patient's health outcome.


Related Articles

  • Clues for New Therapeutics in Osteoporosis. Serhan, Charles N. // New England Journal of Medicine;4/29/2004, Vol. 350 Issue 18, p1902 

    Focuses on the possible development of new therapeutics to treat osteoporosis. Study by Klein and others that identified an enzyme that contributes to natural variations in bone mass and skeletal development in mice; Description of the study and how its findings may impact those who suffer from...

  • New Osteoporosis Therapies Appear Closer. Skolnick, Andrew // JAMA: Journal of the American Medical Association;4/4/90, Vol. 263 Issue 13, p1753 

    Relates the development of therapies for osteoporosis. Information on such therapies; Overview of studies concerning the therapies.

  • Approaches to osteoporosis: Screening and implementing treatment in clinical practice. Rawlins, Susan // Journal of Family Practice;Oct2009 Supplement, Vol. 58 Issue 10, pS39 

    The article focuses on the treatment approaches for osteoporosis. It reviews the criteria in diagnosing and assessing at-risk patients to osteoporosis which helps as a guide for health care providers. It discusses strategies on how to improve persistence and patient's compliance with therapy. It...

  • Combination and Sequential Therapy for Osteoporosis. Heaney, Robert P.; Recker, Robert R. // New England Journal of Medicine;8/11/2005, Vol. 353 Issue 6, p624 

    Comments on the use of combination and sequential therapy for the treatment of osteoporosis. Description of drugs approved in the U.S. for the treatment of osteoporosis; Reference to studies on the use of bone-active agents in clinical treatment of osteoporosis; Efficacy of combination therapies...

  • Content comparison of osteoporosis-targeted health status measures in relation to the International Classification of Functioning, Disability and Health (ICF). Borchers, Michael; Cieza, Alarcos; Sigl, Tanja; Kollerits, Barbara; Kostanjsek, Nenad; Stucki, Gerold // Clinical Rheumatology;Apr2005, Vol. 24 Issue 2, p139 

    The most frequently used instruments for health-related quality of life (HRQL) in patients with osteoporosis are the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41) and the Osteoporosis Assessment Questionnaire (OPAQ 2.0 and OPAQ SV). Since HRQL- and...

  • Follow-up treatment for osteoporosis after fracture. Hooven, Frederick; Gehlbach, Stephen H.; Pekow, Penelope; Bertone, Elizabeth; Benjamin, Evan // Osteoporosis International;Mar2005, Vol. 16 Issue 3, p296 

    Studies of the management of osteoporosis in older women who have had hip or wrist fractures have found underdiagnosis and undertreatment of the disease. Few such studies have been conducted in the United States, however, and most studies have been confined to a subset of the treatments...

  • Is a Calculated Total Hip BMD of Clinical Use? Selby, P. L.; McCloskey, E. V.; Robinson, J.; Smith, I. G.; Potts, B.; Beneton, M. N. C.; Kanis, J. A. // Osteoporosis International;May2000, Vol. 11 Issue 4, p368 

    : The diagnosis of osteoporosis is based on bone mass measurement. To avoid the errors associated with the measurement of spinal bone density the total hip has been accepted as the standard measurement site. This information is not available for many early measurements. We have assessed whether...

  • Postmenopausal Osteoporosis. Rosen, Clifford J. // New England Journal of Medicine;8/11/2005, Vol. 353 Issue 6, p595 

    Presents a case study of the treatment of an older woman with postmenopausal osteoporosis. Symptoms of postmenopausal osteoporosis; Incidence of the condition in the U.S.; Risk for bone fractures associated with osteoporosis; Discussion of the clinical management of postmenopausal osteoporosis,...

  • Review: Parathyroid hormone increases lumbar spine bone mineral density and decreases vertebral fractures in osteoporosis. Cummings, Steven R. // ACP Journal Club;Jul/Aug2003, Vol. 139 Issue 1, p11 

    Provides information on the study on parathyroid hormone (PTH) for treatment of osteoporosis. Types of osteoporosis; Details on PTH treatment; Need for determining the effect of combining antiresorptives and PTH.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics